ENDPOINTS

Biogen taps City Therapeutics in RNAi deal worth up to $1B

Biogen is diving into the RNAi field with City Therapeutics, a biotech led by several former Alnylam leaders. City will apply its RNAi engineering chops and Biogen will supply drug delivery technology to first create ...

May 27, 2025 - 14:24
 0
Biogen taps City Therapeutics in RNAi deal worth up to $1B
Biogen is diving into the RNAi field with City Therapeutics, a biotech led by several former Alnylam leaders. City will apply its RNAi engineering chops and Biogen will supply drug delivery technology to first create ...
Read More

Tags:

Previous Article

Back up and manage your emails easily with Mail Backup X, now $40 for life

Next Article

The diet crazes of the nineteenth century

Related Posts

Enliven stops work on solid tumor drug; Pulmatrix to divest assets

Enliven stops work on solid tumor drug; Pulmatrix to di...

May 15, 2025  0

How PureTech’s lung fibrosis drug stacks up against the competition

How PureTech’s lung fibrosis drug stacks up against the...

May 21, 2025  0

Sanofi, Regeneron report underwhelming data for IL-33 antibody itepekimab, shares drop

Sanofi, Regeneron report underwhelming data for IL-33 a...

May 30, 2025  0